2012
Implementing Provider‐based Sampling for the National Children's Study: Opportunities and Challenges
Belanger K, Buka S, Cherry DC, Dudley DJ, Elliott MR, Hale DE, Hertz‐Picciotto I, Illuzzi JL, Paneth N, Robbins JM, Triche EW, Bracken MB. Implementing Provider‐based Sampling for the National Children's Study: Opportunities and Challenges. Paediatric And Perinatal Epidemiology 2012, 27: 20-26. PMID: 23215706, DOI: 10.1111/ppe.12005.Peer-Reviewed Original ResearchConceptsNational Children's StudyProvider-based samplingChildren's StudyNational cohort studyPrenatal care providersNational probability sampleType of providerProbability sampleCohort studyPrenatal careCare providersChild healthProvider groupsAge 21Risk estimatesPrimary sampling unitsWomenBirthProvidersHealthSampling frameSecondary sampling unitsPregnancyNumber of strategiesUtero
1992
Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid
Ballard R, Ballard P, Bracken M, Moya F, Gross I, Creasy K, Padbury J, Polk D. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. The Lancet 1992, 339: 510-515. PMID: 1346877, DOI: 10.1016/0140-6736(92)90337-3.Peer-Reviewed Original ResearchMeSH KeywordsBetamethasoneChronic DiseaseDouble-Blind MethodDrug Therapy, CombinationFemaleHumansInfant, Low Birth WeightInfant, NewbornInfant, Premature, DiseasesLung DiseasesMalePregnancyPrenatal CareRespiration, ArtificialRespiratory Distress Syndrome, NewbornRisk FactorsThyrotropin-Releasing HormoneConceptsChronic lung diseaseThyrotropin-releasing hormoneRespiratory distress syndromePrenatal thyrotropin-releasing hormoneDistress syndromePostconceptional ageBirthweight infantsLung diseaseSevere respiratory distress syndromeSteroid-alone groupNeonatal respiratory morbidityComplications of prematurityUnadjusted relative riskPrenatal glucocorticoid treatmentWeeks postconceptional ageTRH therapyPreterm deliveryRespiratory morbidityWeeks' gestationGlucocorticoid treatmentNeonatal periodAdverse outcomesTotal incidencePrenatal treatmentRelative risk